You are here:
Home
NICE Guidance
Conditions and diseases
Mental health, behavioural and neurodevelopmental conditions
Dementia
Management of aggression, agitation and behavioural disturbances in dementia: carbamazepine
Evidence summary
Reference number:
ESUOM40
Published:
10 March 2015
This evidence summary has been updated and replaced by
NICE guideline NG97
.
Back to top